230.67 USD
↗ 0.25 (0.11%)PRE MARKET (AS OF 08:01 AM EDT)
Open?$230.40
High?$231.10
Low?$229.95
Prev. Close?$230.42
Volume?8.3K
Avg. Volume?7.5M
VWAP?$230.49
Rel. Volume?0.00x
Bid / Ask
Bid?$230.75 × 200
Ask?$231.02 × 300
Spread?$0.27
Midpoint?$230.89
Valuation & Ratios
Market Cap?554.7B
Shares Out?2.4B
Float?2.4B
Float %?100.0%
P/E Ratio?26.36
P/B Ratio?6.83
EPS?$8.74
Dividend?2.26%
Ex-Dividend?2026-05-26
News
Profile
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Themes
Employees
140.8K
Market Cap
539.8B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1944-09-25
Address
ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.03Adequate
Quick Ratio?0.77Weak
Cash Ratio?0.38Low
Debt/Equity?0.68Moderate
ValuationFAIRLY VALUED
Score61/100
P/E?26.4FAIR▾
P/B?6.83FAIR▾
P/S?5.76FAIR▾
P/FCF?31.9FAIR▾
EV/EBITDA?17.6FAIR▾
EV/Sales?6.10HIGH▾
Returns & Efficiency
ROE?25.9%STRONG▾
ROA?10.5%STRONG▾
Cash Flow & Enterprise
FCF?$17.4B
Enterprise Value?$588.0B
Fundamentals ratios updated end of day